These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 14577862

  • 1. Detrimental role of bradykinin B2 receptor in a murine model of diffuse brain injury.
    Hellal F, Pruneau D, Palmier B, Faye P, Croci N, Plotkine M, Marchand-Verrecchia C.
    J Neurotrauma; 2003 Sep; 20(9):841-51. PubMed ID: 14577862
    [Abstract] [Full Text] [Related]

  • 2. LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats.
    Kaplanski J, Pruneau D, Asa I, Artru AA, Azez A, Ivashkova Y, Rudich Z, Shapira Y.
    J Neurotrauma; 2002 Aug; 19(8):953-64. PubMed ID: 12225655
    [Abstract] [Full Text] [Related]

  • 3. Autoradiographic analysis of mouse brain kinin B1 and B2 receptors after closed head trauma and ability of Anatibant mesylate to cross the blood-brain barrier.
    Ongali B, Hellal F, Rodi D, Plotkine M, Marchand-Verrecchia C, Pruneau D, Couture R.
    J Neurotrauma; 2006 May; 23(5):696-707. PubMed ID: 16689671
    [Abstract] [Full Text] [Related]

  • 4. LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia.
    Ding-Zhou L, Margaill I, Palmier B, Pruneau D, Plotkine M, Marchand-Verrecchia C.
    Br J Pharmacol; 2003 Aug; 139(8):1539-47. PubMed ID: 12922942
    [Abstract] [Full Text] [Related]

  • 5. Effect of LF 16-0687MS, a new nonpeptide bradykinin B2 receptor antagonist, in a rat model of closed head trauma.
    Pruneau D, Chorny I, Benkovitz V, Artru A, Roitblat L, Shapira Y.
    J Neurotrauma; 1999 Nov; 16(11):1057-65. PubMed ID: 10595822
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury.
    Zweckberger K, Plesnila N.
    Neurosci Lett; 2009 Apr 24; 454(2):115-7. PubMed ID: 19429066
    [Abstract] [Full Text] [Related]

  • 10. Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia.
    Zausinger S, Lumenta DB, Pruneau D, Schmid-Elsaesser R, Plesnila N, Baethmann A.
    Brain Res; 2002 Sep 20; 950(1-2):268-78. PubMed ID: 12231253
    [Abstract] [Full Text] [Related]

  • 11. LF 16-0687 Ms, a new bradykinin B2 receptor antagonist, improves neurologic outcome but not brain tissue prostaglandin E2 release in a rat model of closed head trauma combined with ethanol intoxication.
    Asa I, Ivashkova Y, Artru AA, Lifshitz M, Gavrilov V, Azab AN, Kapuler V, Alouchin A, Rachinsky M, Pruneau D, Shapira Y, Kaplanski J.
    J Trauma; 2003 May 20; 54(5):881-7. PubMed ID: 12777900
    [Abstract] [Full Text] [Related]

  • 12. Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation.
    Albert-Weissenberger C, Stetter C, Meuth SG, Göbel K, Bader M, Sirén AL, Kleinschnitz C.
    J Cereb Blood Flow Metab; 2012 Sep 20; 32(9):1747-56. PubMed ID: 22569191
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.
    Blaes N, Pécher C, Mehrenberger M, Cellier E, Praddaude F, Chevalier J, Tack I, Couture R, Girolami JP.
    Am J Physiol Renal Physiol; 2012 Jul 15; 303(2):F293-303. PubMed ID: 22573379
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. B₂ receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibition.
    Bicca MA, Costa R, Loch-Neckel G, Figueiredo CP, Medeiros R, Calixto JB.
    Behav Brain Res; 2015 Feb 01; 278():482-91. PubMed ID: 25446751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.